Lung (small cell) Cancer Lung (small cell)
Conditions
Interventions
1. Standard Regimen:
Multi-drug chemotherapy, cyclophosphamide, adriamycin and vincristine alternating every 21 days with etoposide and cisplatin. A total of six courses, three with each drug combinat
Sponsors
UK Co-ordinating Committee for Cancer Research (UKCCCR)
Eligibility
Inclusion criteria
Inclusion criteria: 1. Histologically or cytologically proven small cell carcinoma of the lung 2. Aged 75 or under 3. Extensive disease and poor prognosis, ie Eastern Cooperative Oncology Group (ECOG) performance status 2 or 3 and/or alkaline phosphatase >1.5 upper limit of normal range 4. Adequate renal function 5. No previous malignancy, except non melanomatous skin cancer in the preceding 3 years 6. No previous chemotherapy or radiotherapy, except for emergency radiotherapy for superior vena cava obstruction 7. No medical contraindications to treatment
Exclusion criteria
Exclusion criteria: Not provided at time of registration
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
United Kingdom
Outcome results
None listed